Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study.
about
Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Safety, efficacy, and persiste ...... lder in Spain: the TRIP study.
@en
Safety, efficacy, and persiste ...... lder in Spain: the TRIP study.
@nl
type
label
Safety, efficacy, and persiste ...... lder in Spain: the TRIP study.
@en
Safety, efficacy, and persiste ...... lder in Spain: the TRIP study.
@nl
prefLabel
Safety, efficacy, and persiste ...... lder in Spain: the TRIP study.
@en
Safety, efficacy, and persiste ...... lder in Spain: the TRIP study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Safety, efficacy, and persiste ...... lder in Spain: the TRIP study.
@en
P2093
Ana María Caro-Murillo
Enric Pedrol
Francisco Vera
Juan Luis Gómez-Sirvent
Koldo Aguirrebengoa
Manuel Angel Castaño
Melchor Riera
Pedro Ferrer
Pere Domingo
Piedad Arazo
P2860
P304
P356
10.1310/HCT1403-204
P577
2013-09-01T00:00:00Z